PE anti-mouse CD45 Antibody

Pricing & Availability
30-F11 (See other available formats)
Regulatory Status
Other Names
T200, Ly-5, LCA
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • 30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
See PE spectral data View Moxi Flow Data
Cat # Size Price Quantity Check Availability Save
103105 50 µg £24.00
Check Availability

Need larger quantities of this item?
Request Bulk Quote
103106 200 µg £48.00
Check Availability

Need larger quantities of this item?
Request Bulk Quote

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Antibody Type
Host Species
Mouse thymus or spleen
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6 and Western blotting7. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
Product Citations
  1. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  2. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  3. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  4. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  5. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  6. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  7. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  8. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
  9. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  10. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  11. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  12. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  13. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  14. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  15. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  16. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  17. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  18. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  19. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  20. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  21. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  22. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  23. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  24. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  25. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  26. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  27. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  28. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  29. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  30. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  31. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  32. Green DP, et al. 2019. Neuron. 101:412. PubMed
  33. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  34. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  35. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  36. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  37. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  38. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  39. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  40. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  41. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  42. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  43. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  44. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  45. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  46. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  47. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  48. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  49. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  50. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  51. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  52. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  53. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  54. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  55. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  56. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  57. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  58. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  59. Liu B, et al. 2013. Development. 140:780. PubMed
  60. Aoki H, et al. 2009. Development. 136:2511. PubMed
  61. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  62. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  63. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  64. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  65. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  66. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  67. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  68. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  69. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  70. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  71. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  72. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  73. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  74. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  75. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  76. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  77. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  78. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  79. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  80. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
  81. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  82. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  83. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  84. Li J, et al. 2021. eLife. 10:00. PubMed
  85. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  86. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  87. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  88. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  89. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  90. Sun D, et al. 2021. Cell Stem Cell. . PubMed
AB_312970 (BioLegend Cat. No. 103105)
AB_312971 (BioLegend Cat. No. 103106)

Antigen Details

Protein tyrosine phosphatase (PTP) family, 180-240 kD

All hematopoietic cells except mature erythrocytes and platelets

Phosphatase, T and B cell activation
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
View information about CD45 on

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 05/14/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.


*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.


BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Insert Note Here
Save Close Clear
Lab Timer
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account